NKGen Biotech, Inc. Warrants (NKGNW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 14Aug 11Oct 16Feb 10Mar 10Mar 13Mar 18Mar 23

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.8x

Market Cap

$867793.72

MomentumView details →

1D Return

+2408.33%

YTD Return

—

RSI (14)

45.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.8x

Market Cap

$867793.72

RSI (14)

45.9

MomentumView details →

1D Return

+2408.33%

YTD Return

—

ProfitabilityView details →

Gross Margin

50.00%

Net Margin

−3612.58%

EBITDA Margin

−1033.90%

ROE (TTM)

46.80%

ROA (TTM)

−148.68%

Asset Turnover

0.08x

GrowthView details →

Revenue YoY

—

EPS YoY

+78.08%

FCF YoY

+6.65%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+71.38%

EBITDA YoY

+91.25%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−0.76x

Current Ratio

0.05x

Quick Ratio

0.05x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

652000.00

Net Income (TTM)

−23.55M

Op. CF (TTM)

−19.65M

Latest newsMore news →

No recent news for NKGNW.

Similar companies

Biodexa Pharmaceuticals PlcBDRX IO Biotech, Inc.IOBT BNB Plus Corp.BNBX Nexera Technologies LtdNEXR Hepion Pharmaceuticals, Inc.HEPA NeuroSense Therapeutics Ltd.NRSNW Find similar companies →

Latest newsMore news →

No recent news for NKGNW.